These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7643458)

  • 21. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.
    Mas A; Rodés J; Sunyer L; Rodrigo L; Planas R; Vargas V; Castells L; Rodríguez-Martínez D; Fernández-Rodríguez C; Coll I; Pardo A;
    J Hepatol; 2003 Jan; 38(1):51-8. PubMed ID: 12480560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
    Morgan MY; Alonso M; Stanger LC
    J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
    Morgan MY
    Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary investigation of intestinal microflora in patients with hepatic cirrhosis].
    Wu X; Xu X; Lu Q; Dai YP; Wu ZM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):817-21. PubMed ID: 23206299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt.
    Riggio O; Balducci G; Ariosto F; Merli M; Pieche U; Pinto G; Tremiterra S; Ziparo V; Capocaccia L
    Dig Dis Sci; 1989 Jun; 34(6):823-9. PubMed ID: 2656134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis.
    Chen C; Li L; Wu Z; Chen H; Fu S
    J Infect; 2007 Jan; 54(1):98-102. PubMed ID: 17049992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma].
    Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K
    Nihon Yakurigaku Zasshi; 1995 Feb; 105(2):97-109. PubMed ID: 7737597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
    Lanthier PL; Morgan MY
    Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.
    Vásconez C; Elizalde JI; Llach J; Ginès A; de la Rosa C; Fernández RM; Mas A; Santamaría J; Bordas JM; Piqué JM; Terés J
    J Hepatol; 1999 Feb; 30(2):260-4. PubMed ID: 10068106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
    Heredia D; Terés J; Orteu N; Rodés J
    J Hepatol; 1988 Aug; 7(1):106-10. PubMed ID: 3053887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.
    Uribe M; Toledo H; Perez F; Vargas F; Gil S; Garcia-Ramos G; Ravelli GP; Guevara L
    Dig Dis Sci; 1987 Dec; 32(12):1345-53. PubMed ID: 3319453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study.
    Pai CH; Huang YS; Jeng WC; Chan CY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):31-6. PubMed ID: 7712392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy.
    Bloom PP; Luévano JM; Miller KJ; Chung RT
    Ann Hepatol; 2021; 25():100333. PubMed ID: 33621653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial activity of rifaximin reduces the levels of benzodiazepine-like compounds in patients with liver cirrhosis.
    Zeneroli ML; Venturini I; Stefanelli S; Farina F; Miglioli RC; Minelli E; Amedei ER; Ferrieri A; Avallone R; Baraldi M
    Pharmacol Res; 1997 Jun; 35(6):557-60. PubMed ID: 9356209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial.
    Uribe M; Campollo O; Vargas F; Ravelli GP; Mundo F; Zapata L; Gil S; Garcia-Ramos G
    Hepatology; 1987; 7(4):639-43. PubMed ID: 3301614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of anaerobic gram-negative bacteria in hepatic encephalopathy and the therapeutic effects of vancomycin hydrochloride on hepatic encephalopathy].
    Tarao K; Ikeda T; Hayashi K; Sakurai A
    Nihon Shokakibyo Gakkai Zasshi; 1985 Aug; 82(8):1875-83. PubMed ID: 4068308
    [No Abstract]   [Full Text] [Related]  

  • 37. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
    Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
    Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
    Wang LJ; Cai JT; Chen T; Lü B; Si JM
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy.
    Bird SP; Hewitt D; Ratcliffe B; Gurr MI
    Gut; 1990 Dec; 31(12):1403-6. PubMed ID: 2265782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
    Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
    Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.